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Introduction 
Epilepsy is one of the oldest neurological conditions 
known  to  humankind  and  as  a  major  public  health 
problem  worldwide,  it  afflicts  0.5–1%  of  the 
population  in  industrialized  countries.
1,2  There  are 
many  therapeutic  strategies  for  epilepsy  such  as 
pharmaceutical  agents,  administration  of  gonadal 
steroids,  neurotrophic  factors,  dietary  interventions 
and  hormones.  The  effects  of  hormones  either 
peripheral or endogenous on the nervous system have 
been  well-established.
3  Ghrelin  is  a  brain-gut 
hormone,  which  is  mainly  produced  by  stomach.
4,5 
Other  tissues  that  express  ghrelin  include  different 
hypothalamic  nuclei  such  as  arcuate  nucleus, 
ventromedial  nucleus,  dorsomedial  nucleus, 
paraventricular  nucleus;  ependymal  layer  of  third 
ventricle, pituitary, hippocampus, immune cells, lung, 
placenta, kidney, ovary and testis.
6 Ghrelin receptor is 
located  in  hypothalamus  nuclei,  hypophysis,  and 
different brain regions such as CA1, CA2, CA3 and 
dentate  gyrus  of  hippocampal  formation,  substantia 
nigra, ventral tegmental region, raphe nucleus, nodose 
ganglion and cortex.
6,7 Therefore, hippocampus could 
be a target for the central effects of ghrelin.
8 
Ghrelin is a multifaceted peptide hormone.
5 Ghrelin 
stimulates  GH  secretion,  increases  food  intake,  and 
decreases  fat  utilization.
9  Concerning  ghrelin’s 
behavioral  effects,  it  has  been  reported  that 
intracerebroventricular administration in rats induced 
anxiety and improved memory retention.
10 Recently, 
Obay  etal  2007,  demonstrated  that  dose-dependent 
ghrelin  administration  significantly  delay  the  onset 
time  of  the  first  myoclonic  jerk,  generalized  clonic 
seizure and tonic generalized extension, diminish the 
duration of tonic generalized extension and suppress 
the onset time of PTZ-induced seizures.
11 Moreover, 
activation  of  the  ghrelin  receptor  results  in  the 
attenuation of seizures in pilocarpine-induced limbic 
seizures in rats.
12 Ghrelin protects against cell death 
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Purpose:  Ghrelin  has  been  shown  to  have  antiepileptic  function.  However,  the 
underlying  mechanisms  by  which,  ghrelin  exerts  its  antiepileptic  effects  are  still 
unclear.  In  the  present  study;  we  investigated  antiepileptic  mechanism  of  ghrelin 
through  GABAB receptors  using  CGP35348  (selective  GABAB  receptor  antagonist). 
Methods: Male Wistar rats' hippocampi were bilaterally microinjected with the single 
dose  or  10-day  ghrelin  (0.3  nmol/µl/side).  CGP35348,  GABAB  receptor  antagonist, 
(12.5  µg/µl/side)  or  saline  injected  into  the  dorsal  hippocampus  20  minutes  before 
ghrelin administration. Thirty min after ghrelin microinjection, a single convulsive dose 
of pentylenetetrazole (PTZ) (50 mg/kg) was injected intraperitoneally (i.p). Afterwards, 
seizure  duration  and  total  seizure  score  (TSS)  were  assessed  for  30  minutes  in  all 
animals. Results:  Our results demonstrated  that acute and chronic intrahippocampal 
(i.h.) injection of ghrelin could significantly (p<0.001) attenuate the severity of seizures. 
Ghrelin  0.3  nmol/µl/side  decreased  duration  of  seizure  significantly  both  in  acute 
(p<0.001)  and  chronic  (p<0.01)  injections.  The  ghrelin  antiepileptic  effect  was 
completely antagonized by GABAB blockade. The suppression of both duration and 
TSS  induced  by  ghrelin  in  hippocampus  was  significantly  (p<0.001)  blocked  by 
CGP35348 in PTZ-induced seizures. Conclusion: In summary, our findings suggest 
that  GABAB  receptors  may  mediate  the  antiepileptic  action  of  ghrelin  in  the 
hippocampus. Therefore, it is possible to speculate that ghrelin acts in the hippocampus 
to modulate seizures via GABA. 
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of  hippocampal  neurons  in  pilocarpine-induced 
seizures in rats and promotes the formation of spine 
synapses in the stratum radiatum of the CA1 subfield 
of the hippocampal formation.
7,13 
Epilepsy is thought to be due to an imbalance between 
glutamate  mediated  excitatory  and  GABAergic 
inhibitory  networks,  changes  in  ionotropic  receptor 
function  and  composition,  altered  calcium-mediated 
second  messenger  activity,  or  altered  endogenous 
anticonvulsant and neuroprotective activities.
14 
GABA is the major inhibitory neurotransmitter in the 
central nervous system (CNS) and as such plays a key 
role in modulating neuronal activity.
15 GABA acts on 
two types of receptors, namely GABAA, the ligand-
operated  ion  channels,  and  GABAB,  the  G  protein 
coupled metabotropic receptors. GABAA receptors are 
responsible for fast inhibitory postsynaptic potential 
(IPSP),  whereas  GABAB  receptors  cause  slower 
IPSP.
16  Postsynaptic  GABAB  receptors  trigger  the 
opening of K
+ channels through the G subunits. This 
results  in  a  hyperpolarization  of  the  postsynaptic 
neuron. Moreover, GABAB activates Ca
2+ sensitive K
+ 
channels  and  small  conductance  K
+  channels  in  rat 
hippocampal neurons.
15 
Ghrelin  may  exert  modulatory  effects  on 
neurotransmission.
9  The  possible  involvements  of 
GABA  in  the  ghrelin-mediated  effects  have  been 
previously  shown.  Orexigenic  action  and  appetite 
stimulation  of  ghrelin,  directly  or  indirectly  is 
mediated through GABA.
9,17-19 
The present study was designed to investigate ghrelin 
possible  antiepileptic  mechanism  through  GABAB 
receptor  using  CGP  35348  (a  selective  GABAB 
receptor antagonist). 
 
Materials and Methods 
Chemicals and Drugs 
Rat ghrelin, CGP3534 and PTZ were purchased from 
Tocris  Bioscience  (Bristol,  UK).  Ghrelin  was 
dissolved in saline (1mg/100µl), and stocked at -20°C. 
Immediately  before  i.h.  microinjection,  ghrelin  was 
diluted with 0.9% saline to give a final concentration 
of  0.3nmol/µl.  The  control  group  received  equal 
amount of saline (1µl). CGP35348 was dissolved in 
saline  (1mg/100µl)  and  i.h.  injection  of  12.5 
μg/µl/side performed. 
 
Animals and Treatment 
The Regional Ethics Committee of Tabriz University 
of  Medical  Sciences  approved  all  experimental 
procedures. Every effort was made to minimize the 
number of used animals and their suffering. Animals 
were obtained from the colony of Tabriz university of 
Medical Sciences. The experiments were performed in 
adult male Wistar rats (n=50) weighing 220-250 g at 
the beginning of experiments. They were housed in a 
temperature (22±2 °C) and humidity-controlled room. 
The animals were maintained under a 12:12-h light/ 
dark cycle, with lights off at 8:00 p.m. Food and water 
provided  ad  libitum  except  for  the  periods  of 
behavioral testing. The behavioral testing was  done 
during the light phase. 
 
Surgery 
Rats were implanted with bilateral canula aimed at the 
dorsal  hippocampus.  Before  surgery,  animals  were 
anesthetized  with  i.p.  injection  of  ketamine  (60 
mg/kg) and xylazine (12 mg/kg). The animals were 
mounted into a stereotaxic frame used to position the 
22-gauge  stainless  steel  guide  canula  in  the  dorsal 
hippocampus. Coordinates obtained from Paxinos and 
Watson brain atlas (mm from bregma: AP= -3.8; ML 
= ± 2.2; DV = -2.7).
20 The guide canula was anchored 
to the skull using stainless steel screws and acrylic 
cement. The animals were allowed 7 days recovery 
after guide canula surgeries before the behavioral test. 
 
Microinjection Procedure 
All  microinjections  were  done  slowly  (1  µl/2  min) 
using  a  5µl  Hamilton  syringe  connected  by  Pe-20 
polyethylene tube. The stainless steel injection needle 
(30 G) was cut to protrude 0.5 mm beyond the tips of 
the guide cannulae and left in place for 1 min after 
injection  to  allow  diffusion  of  the  solution  and  to 
prevent back flow. 
Saline or ghrelin 0.3 nmol/μl were injected bilaterally 
in dorsal hippocampus for 10 day. At the tenth day, 
ghrelin was injected 30 min before intraperitoneally 
(i.p.) injection of PTZ with a single convulsive dose 
of 50 mg/kg. 
CGP 35348 was used to evaluate the role of GABAB 
receptors  in  antiepileptic  effect  of  ghrelin.  The 
conscious animals were gently restrained by hand, the 
injection  needle  was  inserted  through  the  guide 
cannulae, and saline or CGP 35348 and ghrelin (0.3 
nmol/μl),  were  sequentially  injected.  A  twenty  min 
interval between i.h. injection of receptor antagonist 
or saline and ghrelin was considered. Thirty minutes 
after the last microinjection, a single convulsive dose 
of  PTZ  (50  mg/kg)  was  administered 
intraperitoneally.  The  doses  and  administration 
schedule of antagonist were established in accordance 
with  some  earlier  studies.  The  dose  of  ghrelin  was 
obtained  according  to  the  lowest  effective  dose  to 
inhibit seizure.
21 Microinjections were done between 
9:00 and 12:00 a.m. to prevent variations determined 
by circadian rhythms. 
 
Seizure Assessment 
The rats were housed in Plexiglas cages (50 cm   50 
cm   40 cm) after PTZ injection and their behavior 
was observed and videotaped for 30 min. The latency 
to  seizure  onset,  duration,  and  severity  of  seizures 
were  monitored  as  parameters  of  seizure  in  all 
animals. Then videotapes were reviewed, and detected 
seizures  were  scored  based  on  Racine’s  scale  as 
following:  (0)  normal,  nonepileptic  activity;  (1) 
mouth  and  facial  movements,  hyperactivity,  
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grooming,  sniffing,  scratching,  wet  dog  shakes;  (2) 
head  nodding,  staring,  tremor;  (3)  forelimb  clonus, 
forelimb  extension;  (4)  rearing,  salivating,  tonic 
clonic activity;  (5)  falling,  status  epilepticus.
22  Rats 
were  assigned  a  seizure  score  (SS)  for  each  5  min 
interval over the course of the 30 min session, after 
which a mean SS was calculated for the entire 30 min 
session for each rat and referred as total seizure score 
(TSS).
23 
 
Experimental Design 
After 7 days of recovery rats were randomly divided 
into five groups (n = 10) as follows: 
  Group (saline): 1 µl/side saline i.h. 
  Group (acute ghrelin): a single dose of 0.3 
nmol/µl/side ghrelin i.h. 
  Group  (chronic  ghrelin):  0.3  nmol/µl/side 
ghrelin i.h. for 10 days 
  Group (saline + ghrelin): 1µl/side saline 20 
min before 0.3 nmol/µl/side ghrelin i.h. 
  Group  (CGP35348  +  ghrelin):  12.5 
μg/µl/side  CGP35348,  20  min  before  0.3 
nmol/µl/side ghrelin i.h. 
Then, PTZ (50 mg/kg) was injected intraperitoneally 
30 min after the administration of ghrelin or saline in 
all groups. 
On  completion  of  each  experiment,  the  rats  were 
sacrificed,  their  brains  were  removed,  fixed  in 
formalin, and injection sides were verified in coronal 
sections. Only animals with the correct injection sides 
were taken for a further analysis. 
 
Statistical Analysis 
Data are expressed, as means ± S.E.M. The statistical 
analysis  of  the  data  was  carried  out  by  one-way 
ANOVA-followed  by  Tukey's  test.  In  all 
comparisons, P<0.05 was considered significant. 
 
Results 
The Effect of Acute and Chronic Intrahippocampal 
Microinjection of Ghrelin on the Latency to Seizure 
Onset,  Duration  of  Seizures  and  the  Total  Seizure 
Score in Epileptic Rats 
As shown in Figure 1, a one-way ANOVA indicated 
that latency to seizure onset after microinjection of 
single  dose  and  10-day  ghrelin  (0.3  nmol/µl/side), 
was not significant. 
The  effect  of  acute  and  chronic  microinjection  of 
ghrelin  on  duration  of  seizures  was  determined. 
Single dose of ghrelin 0.3 nmol/µl/side decreased the 
duration of seizures and it was extremely significant 
(p<0.001)  with  respect  to  saline  group.  Animals 
treated with ghrelin 0.3 nmol/µl/side for 10 days had 
also significantly (p<0.01) reduced duration. But the 
difference in duration of seizure between acute and 
chronic ghrelin was not significant (Figure 2). 
 
 
Figure 1. Effect of single dose and 10 days intrahippocampal 
microinjection  of  ghrelin  (0.3  nmol/µl/side)  on  the  latency  to 
onset in PTZ-induced seizure. Results are expressed as mean 
± SEM; n=10 animals per group. 
 
 
 
Figure 2. Effect of single dose and 10 days intrahippocampal 
microinjection of ghrelin (0.3 nmol/µl/side) on the duration in 
PTZ-induced seizure. Results are expressed as mean ± SEM; 
n=10 animals per group; ** p<0.01, *** p<0.001. 
 
As illustrated in Figure 3, a repeated measure ANOVA 
revealed that ghrelin 0.3 nmol/µl/side could decrease total 
seizure  score  (scores  during  30  minutes)  significantly 
(p<0.001) both in the single dose and 10 - day groups, 
compared with saline group. 
 
The  Effect  of  Intrahippocampal  Microinjection  of 
CGP35348 on the Latency to Seizure Onset, Duration 
of Seizures and Total Seizures Score in Epileptic Rats 
Pre-treatment  with  CGP35348  (GABAB  receptor 
antagonist),  in  dorsal  hippocampus,  20  min  prior  to 
ghrelin administration reversed the antiepileptic effects 
of  ghrelin.  CGP35348  administration  significantly 
prolonged  duration  of  seizures  (p<0.001)  (Figure  4) 
and intensified total seizure score (p<0.001) (Figure 5). 
Intrahippocampal  administration  of  CGP35347  alone 
did not induce convulsion (figure is not shown).  
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Figure 3. Effect of single dose and 10 days intrahippocampal 
microinjection of ghrelin (0.3 nmol/µl/side) on the total seizure 
score in PTZ-induced seizure. Results are expressed as mean 
± SEM; n=10 animals per group, *** p<0.001. 
 
 
Figure  4.  Effect  of  intrahippocampal  injection  of  ghrelin 
preceded by CGP35348 (GABAB receptor antagonist) or saline 
on  the  duration  of  seizures  during  the  30-min  post-PTZ 
behavior assessment. Results are expressed as mean ± SEM, 
n=10 animals per group; *** P<0.001.  
 
 
Figure  5.  Effect  of  intrahippocampal  injection  of  ghrelin 
preceded by CGP35348 (GABAB receptor antagonist) or saline 
on the total seizure score during the 30-min post-PTZ behavior 
assessment.  Results  are  expressed  as  mean  ±  SEM,  n=10 
animals per group; *** P<0.001. 
Discussion 
In the present study, we assessed the antiepileptic effect 
of acute and chronic i.h. microinjection of ghrelin and 
one  of  the  possible  mechanisms  of  ghrelin  action 
through  GABAB  receptors  (CGP35348).  To  evaluate 
the  contribution  of  specific  receptor  subtype  to  the 
anticonvulsant actions of ghrelin we used PTZ model 
of epilepsy. Our findings demonstrated that acute and 
chronic  microinjection  of  ghrelin  to  dorsal 
hippocampus could significantly attenuate the severity 
and  duration  of  seizures.  In  addition,  our  findings 
demonstrated  that  CGP35348,  GABAB  receptors 
antagonist, completely antagonized antiepileptic effects 
of ghrelin in the dorsal hippocampus. 
Ghrelin  is  a  peptide  that  expresses  in  a  variety  of 
tissues,  and  it  plays  a  role  in  physiological  and 
pathophysiological  conditions.
4  Growth  hormone 
release and stimulation of feeding] are the most known 
physiological functions for ghrelin.
6,10,24 Other findings 
indicate a role for ghrelin in mediating neuroprotective 
and behavioral responses. The neuroprotective action 
of  ghrelin  has  been  evidenced  in  different  animal 
models  of  neuronal  injury,  such  as  cerebral 
ischemia/reperfusion  neuronal  loss,  dopaminergic 
neurodegeneration  and  pilocarpine-induced 
hippocampal  neuronal  loss.
13,25  Ghrelin  can  also 
promote  dendritic  spine  synapse  formation  and 
neurogenesis  in  adult  rat.
7,26  Recently,  it  has  been 
shown  that ghrelin  or its  agonists have  anti-epileptic 
action in rodents.
11,12,27 Our results in acute and chronic 
10-day intrahippocampal administration of ghrelin are 
in accordance with Obay etal 2007 and Aslan etal 2009 
studies. Therefore, ghrelin could be a potential benefit 
treatment for relieving the intensity of epilepsy and the 
hippocampal neuron demise caused by seizures. 
A number of naturally occurring brain substances, such 
as  GABA,  adenosine,  and  the  neuropeptides  galanin 
and  neuropeptide  Y,  may  function  as  endogenous 
anticonvulsants and, in addition, may interact with the 
process of epileptogenesis. GABA is one of the main 
inhibitory  neurotransmitters  in  the  brain.
28  Focal 
augmentation  of  GABA  in  the  limbic  system  is  an 
obvious strategy for seizure control.
14 
GABAB receptors are G protein–linked receptors that 
hyperpolarize  the  neuron  by  increasing  potassium 
conductance. GABAB receptors decrease calcium entry 
and have a slow inhibitory effect.
29 The involvement of 
GABAB  receptors  in  controlling  seizures  has  been 
reported  in  various  models  of  epilepsy.
30  GABAB 
receptors are important in controlling partial or tonic – 
clonic seizures, despite their role in enhancing absence 
seizures.
31 Seizure disorders are often associated with a 
decreased  efficacy  of  GABA  receptor-mediated 
inhibition  that  is  mainly  mediated  by  two  receptor 
subtypes  (termed  A  and  B)  located  pre-  and 
postsynaptically  on  both  interneurons  and  principal 
cells.
32  GABAB  receptors  are  considered  promising 
drug  targets  for  the  treatment  of  neurological  and 
mental  health  disorders.
33  CGP  35348  is  a  selective  
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GABAB receptor antagonist and It is used as a tool in 
the studies of the role of GABAB receptors in brain.
34 
GABA mediates ghrelin action, in some areas of CNS. 
In  mouse  spinal  cord  slices,  have  been  show  that 
ghrelin  significantly  enhances  inhibitory 
(GABAergic/glycinergic)  neurotransmission.
35  In 
arcuate nucleus ghrelin hyperpolarizes POMC neurons 
that, likely mediated by the GABAergic NPY/AGRP 
neurons.
9  Circulating  ghrelin  enter  the  hippocampus, 
where specially has been shown to be a critical region 
for  temporal  lobe  epilepsy,  and  bind  to  the 
hippocampal  neurons.
3,13  It  is  possible  that  ghrelin 
affect epilepsy parameters through GABAB receptors. 
Our  findings  showed  that  intrahippocampal 
administration  of  the  GABAB  receptor  antagonist, 
CGP35348; prior to intrahippocampally administration 
of ghrelin antagonize the antiepileptic effect of ghrelin 
in  PTZ-induced  seizures  in  rats.  Therefore,  it  is 
possible  to  speculate  that  ghrelin  acts  in  the 
hippocampus to modulate seizures via GABAB receptor 
dependent mechanism. The anti-epileptiform effects of 
ghrelin may be due to the stimulation of GABA release. 
It is beneficiary to measure GABA level after ghrelin 
administration  to  prove  that  ghrelin  acts  through 
GABA  release  to  control  limbic  seizures  in  dorsal 
hippocampus. 
 
Conclusion 
In  conclusion  in  vivo,  acute  and  repeated  i.h. 
applications of ghrelin exert anticonvulsant properties 
on  seizures  of  PTZ-induced  model.  The  anti-
epileptiform  action  of  ghrelin  was  diminished  by 
GABAB  selective  antagonist,  CGP  35348.  Therefore, 
these  findings  may  imply  on  GABAB  receptors 
participate in the anti-epileptiform activity of ghrelin. 
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